机构:[1]Department of Neurology, Peking Union Medical College Hospital, 1 Shuaifuyuan, Dongcheng District, 100730 Beijing, China[2]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China神经内科首都医科大学宣武医院
Neuromyelitis optica (NMO) is an antibody-mediated disease with the target antigen being the water channel aquaporin-4 (AQP4). More than 90% of NMO patients have relapse. Optimal treatments to prevent recurrence have not been established. Previous reports suggest that interferon beta (IFNB) has not been effective in NMO. However, we present a case of NMO with positive anti-myelin oligodendrocyte glycoprotein (MOG)(27-38) IgG and anti-AQP4 IgG treated with IFNB-1a successfully. The effect of IFNB on NMO and the role of anti-MOG antibodies in NMO deserve further study.
第一作者机构:[1]Department of Neurology, Peking Union Medical College Hospital, 1 Shuaifuyuan, Dongcheng District, 100730 Beijing, China
通讯作者:
通讯机构:[1]Department of Neurology, Peking Union Medical College Hospital, 1 Shuaifuyuan, Dongcheng District, 100730 Beijing, China
推荐引用方式(GB/T 7714):
Yan Xu,Yao Zhang,Jing Ye,et al.Successful treatment of a woman with relapsing neuromyelitis optica by interferon beta[J].NEUROLOGICAL SCIENCES.2012,33(4):911-913.doi:10.1007/s10072-011-0849-0.
APA:
Yan Xu,Yao Zhang,Jing Ye,Bin Peng,Jian-Ming Wang&Li-Ying Cui.(2012).Successful treatment of a woman with relapsing neuromyelitis optica by interferon beta.NEUROLOGICAL SCIENCES,33,(4)
MLA:
Yan Xu,et al."Successful treatment of a woman with relapsing neuromyelitis optica by interferon beta".NEUROLOGICAL SCIENCES 33..4(2012):911-913